Time to direct-acting antiviral initiation and liver-related events in people with HIV and hepatitis C virus
Almost one-quarter of people with HIV-HCV co-infection on ART had not initiated DAA 3 years after HIV virologic suppression. Because the 3-year risk of liver-related events was low, estimates of the impact of delayed DAA initiation were imprecise.
Authors
- Roger Logan
- Linda Wittkop (ORCID: https://orcid.org/0000-0003-2403-0960)
- Rachel Epstein (ORCID: https://orcid.org/0000-0003-2831-8865)
- Massimo Puoti (ORCID: https://orcid.org/0000-0003-3278-7138)
- Mathieu Chalouni (ORCID: https://orcid.org/0000-0002-0016-8896)
- Anders C. Boyd (ORCID: https://orcid.org/0000-0001-9512-8928)
- Bernard Surial (ORCID: https://orcid.org/0000-0002-1402-974X)
- Marina B. Klein (ORCID: https://orcid.org/0000-0002-3063-8430)
- Jim Young (ORCID: https://orcid.org/0000-0002-4314-3007)
- Christopher T. Rentsch (ORCID: https://orcid.org/0000-0002-1408-7907)
- Juan Berenguer (ORCID: https://orcid.org/0000-0001-8541-8200)
- Sara Lodi (ORCID: https://orcid.org/0000-0002-9419-7830)
- Inmaculada Jarrín (ORCID: https://orcid.org/0000-0002-7485-2252)
- Sophia M. Rein (ORCID: https://orcid.org/0000-0002-5240-4838)
- Robert Zangerle (ORCID: https://orcid.org/0000-0002-5375-7299)
- Benjamin P. Linas (ORCID: https://orcid.org/0000-0002-9781-9690)
- José María Miró (ORCID: https://orcid.org/0000-0001-8057-7755)
- Daniela K van Santen (ORCID: https://orcid.org/0000-0002-9890-4694)
- M. John Gill (ORCID: https://orcid.org/0000-0002-8546-8790)
- Giota Touloumi (ORCID: https://orcid.org/0000-0002-5951-0844)
- Jessie Torgersen (ORCID: https://orcid.org/0000-0002-7861-1421)
- Miguel A. Hernán (ORCID: https://orcid.org/0000-0003-1619-8456)
- Andri Rauch (ORCID: https://orcid.org/0000-0001-5297-6062)
- Antonios Papadopoulos
- Marc van der Valk (ORCID: https://orcid.org/0000-0002-8290-6425)
- Antonella d’Arminio Monforte
Institutions
- Boston University (US)
- University of Bern (CH)
- Boston Medical Center (US)
- United States Department of Veterans Affairs (US)
- Institut national de recherche en sciences et technologies du numérique (FR)
- Harvard University (US)
- Innsbruck Medical University (AT)
- Université de Bordeaux (FR)
- Inserm (FR)
- University of Calgary (CA)
- National and Kapodistrian University of Athens (GR)
- University Hospital of Bern (CH)
- Instituto de Salud Carlos III (ES)
- McGill University Health Centre (CA)
- Hospital General Universitario Gregorio Marañón (ES)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Yale University (US)
- VA Connecticut Healthcare System (US)
- London School of Hygiene & Tropical Medicine (GB)
- Cancer Research And Biostatistics (US)
- Bordeaux Population Health (FR)
- National Institute Of Hygiene And Epidemiology (VN)
- Stichting HIV Monitoring (NL)
- Alberta Hip and Knee Clinic (CA)
- Centre Inria de l'université de Bordeaux (FR)
- Institute of Medical Microbiology and Hygiene (DE)
- Amsterdam University Medical Centers (NL)
- Center for Clinical Research (United States) (US)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- McGill University (CA)
- Universitat de Barcelona (ES)
- University of Pennsylvania (US)
- University of Amsterdam (NL)
Publication Details
- Journal
- AIDS
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1097/qad.0000000000004161
- Citations
- 2
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- Pfizer
- Gilead Sciences
- ViiV Healthcare
- National Institutes of Health
- Genentech
- Center for AIDS Research, University of Washington